Strategies to Help Adult ED Patients Quit Smoking
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine whether a brief, focused intervention in the hospital emergency department is effective in helping adults quit smoking.
| Condition | Intervention |
|---|---|
|
Tobacco Use |
Drug: transdermal nicotine patches Behavioral: Motivational interview |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Strategies to Help Adult ED Patients Quit Smoking |
- 3-month cessation rate
- 3-month quit attempts,
- daily cigarette consumption,
- stage of change assessment
| Estimated Enrollment: | 336 |
| Study Start Date: | January 2006 |
| Estimated Study Completion Date: | April 2007 |
In urban communities, the prevalence of tobacco use among adults visiting a hospital emergency department (ED) nears 40%, well in excess of the 25% smoking prevalence rate of the general population. Many of these patients lack easy access to primary care, suggesting the ED may be an attractive locus to initiate tobacco cessation efforts. With over 100 million annual visits to U.S. EDs, it may be possible to engage millions of smokers in tobacco cessation efforts. The major purpose of this study is to examine whether a multicomponent intervention delivered in the ED by a Lay Educator to adult smokers interested in quitting is more likely to result in cessation than usual care. A secondary goal is to test whether patients who present to the ED with a tobacco-related illness (as indicated by ICD9 code) are more likely to quit than ED smokers with a non-tobacco-related condition. This will allow us to test the validity of the “teachable moment” as an opportune time to engage patients in considering a behavioral change. The proposed study is a randomized trial of a motivational interview, provision of six weeks' worth of nicotine patches, literature, and post-visit follow-up (Enhanced Care) vs. referral to a cessation clinic (Minimal Care) for ED patients who smoke. Eligibility criteria: age > 21 years, contemplation or preparation stage of change, not admitted to hospital. All patients will undergo a standardized stage of change assessment, and measurements of nicotine dependence and exhaled carbon monoxide. All will receive a cessation fact sheet and referral card to the smoking cessation clinic; the cards of those in the Enhanced Care group will have a specific appointment date and time. The Enhanced Care group will receive a language-appropriate pamphlet discussing smoking cessation. We will record the ICD9 codes associated with each visit. Major outcome measure: cessation within 3 months of the ED visit, stratified by treatment group. Secondary outcome measure: cessation within 3 months of the ED visit, stratified by whether the visit was smoking-related. If smokers receiving Enhanced Care are more likely to quit, then the ED could be considered a new, effective locus for tobacco control, potentially reaching several million smokers. If patients with a smoking-related diagnosis for the ED visit are more likely to quit than those with non-smoking-related ICD9, then this supports the construct of the teachable moment.
Eligibility| Ages Eligible for Study: | 21 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- >= 10 cigarettes smoked daily
- being discharged from the ED
- contemplation or preparation stage of change
- speaks English or Spanish
Exclusion Criteria:
- being admitted to hospital
- too ill to consent
Contacts and Locations| Contact: Steven L. Bernstein, MD | 718-920-2068 | sbernste@montefiore.org |
| Contact: Deepa Prasad, MPH | 718-430-2985 | dprasad@aecom.yu.edu |
| United States, New York | |
| Montefiore Medical Center | Recruiting |
| Bronx, New York, United States, 10467 | |
| Sub-Investigator: Lisa Cabral, MD | |
| Principal Investigator: Steven L. Bernstein, MD | |
| Principal Investigator: | Steven L. Bernstein, MD | Albert Einstein College of Medicine of Yeshiva University |
More Information
No publications provided by National Institute on Drug Abuse (NIDA)
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| ClinicalTrials.gov Identifier: | NCT00297466 History of Changes |
| Other Study ID Numbers: | DA017812 |
| Study First Received: | February 24, 2006 |
| Last Updated: | February 24, 2006 |
| Health Authority: | United States: Federal Government United States: Institutional Review Board |
Keywords provided by National Institute on Drug Abuse (NIDA):
|
tobacco use smoking cessation emergency department |
Additional relevant MeSH terms:
|
Smoking Habits Nicotine Ganglionic Stimulants Autonomic Agents Peripheral Nervous System Agents Physiological Effects of Drugs |
Pharmacologic Actions Nicotinic Agonists Cholinergic Agonists Cholinergic Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action |
ClinicalTrials.gov processed this record on May 22, 2013